Related by context. All words. (Click for frequent words.) 69 inhospital 69 reinfarction 68 repeat revascularization 66 recurrent ischemia 65 recurrent myocardial infarction 65 periprocedural 64 postoperative mortality 64 upper gastrointestinal bleeding 64 myocardial infarction stroke 64 coronary revascularization 64 nonfatal MI 64 perioperative mortality 64 ICD implantation 64 postoperative complications 63 cardiovascular hospitalizations 63 postoperative complication 62 ipsilateral stroke 62 readmissions 62 readmission rates 62 HF hospitalization 62 VT VF 62 cardiovascular hospitalization 62 rehospitalizations 62 nonfatal myocardial infarction 62 CRBSI 62 recurrent VTE 62 postoperative infections 62 refractory ischemia 62 MACCE 61 myocardial infarction MI 61 hemorrhagic complications 61 de ath 61 severe exacerbations 61 inpatient hospitalization 61 perioperative complications 61 NSTEMI 60 thrombolytic therapy 60 arterial thromboembolic events 60 target vessel revascularization 60 VTE prophylaxis 60 postoperative pulmonary 60 revascularization procedures 60 revascularization procedure 60 acute myocardial infarction AMI 60 binary restenosis 60 anticoagulation therapy 60 rebleeding 60 ADEs 60 abnormal mammograms 60 revascularisation 60 posttransplant 60 hypoglycemic events 60 nonadherence 60 unnecessary readmissions 60 asthma exacerbations 60 thrombotic events 60 beta blocker therapy 60 cerebrovascular events 59 unplanned readmissions 59 platelet reactivity 59 anastomotic leak 59 severe hypoglycemic 59 colectomy 59 revascularization 59 MIs 59 macrovascular events 59 postdischarge 59 recurrent venous thromboembolism 59 noncardiac surgery 59 postoperative AF 59 percutaneous coronary interventions 59 Events MACE 59 inhospital mortality 59 acute myocardial infarctions 59 ICD shocks 59 recurrent stroke 59 peri procedural 59 nonfatal myocardial infarction MI 58 postoperative infection 58 nonfatal stroke 58 myocardial infarction 58 Nesiritide 58 STEMI patients 58 postoperative bleeding 58 LV dysfunction 58 COPD exacerbations 58 PSADT 58 Hospitalizations 58 venous thromboembolic disease 58 resynchronization therapy 58 reperfusion therapy 58 undergoing coronary angiography 58 reintervention 58 antithrombotic therapy 58 rehospitalized 58 postsurgical 58 virologic failure 58 LVSD 58 CMV infection 58 afib 58 postprocedure 58 cardiogenic shock 58 severe hypoglycemia 58 acute coronary 58 thromboembolism 58 DVT PE 58 A1c levels 58 ruptured aneurysms 58 syncopal 57 endarterectomy 57 noncardiac 57 undergoing CABG 57 recurrent DVT 57 acute STEMI 57 hyperkalemia 57 psychiatric hospitalization 57 Stent thrombosis 57 thromboprophylaxis 57 acute myocardial infarction 57 preventable hospitalizations 57 CLABSIs 57 pancreatic resection 57 postoperative morbidity 57 postoperative delirium 57 angiographic restenosis 57 Major Adverse Cardiac 57 Readmissions 57 PCIs 57 atherothrombotic disease 57 Erythropoietic therapies may 57 reoperations 57 myocardial infarctions 57 thromboembolic 57 avoidable hospitalizations 57 treat NNT 57 carotid endarterectomy 57 definite stent thrombosis 57 CCyR 57 coronary intervention 57 postoperative atrial fibrillation 57 intravenous diuretics 57 artery reclogging 57 comorbid conditions 57 thromboembolic events 57 perioperatively 57 Caesarean deliveries 57 hospitalization 57 asymptomatic PAD 57 nonfatal heart 57 postsurgical complications 57 revascularizations 57 ST elevation myocardial 57 fluid overload 57 antimicrobial prophylaxis 56 Y BOCS 56 pretest probability 56 neurologic complications 56 inpatient hospitalizations 56 carotid stenosis 56 tirofiban 56 symptomatic VTE 56 intensive statin therapy 56 CDI recurrence 56 acute coronary syndrome 56 hemodynamic instability 56 antibiotic prophylaxis 56 NSTE ACS 56 thrombotic complications 56 tachyarrhythmias 56 CLABSI 56 medication nonadherence 56 reinterventions 56 decompensated heart failure 56 annualized relapse 56 recurrent atrial fibrillation 56 TMP SMX 56 coronary revascularization procedures 56 patients undergoing CABG 56 anticoagulation 56 stent placement 56 pacemaker implantation 56 sustained ventricular tachycardia 56 nocturnal hypoglycemia 56 aneurysm ruptures 56 extubation 56 HSCT 56 left ventricular dysfunction 56 neurodevelopmental impairment 56 ejection fractions 56 PSA nadir 56 composite endpoint 56 hospitalizations 56 preintervention 56 postintervention 56 sustained virologic response 56 variceal bleeding 56 noncardiovascular mortality 56 silent ischemia 56 eptifibatide 56 asthma exacerbation 56 severe asthma exacerbations 56 primary percutaneous coronary 56 oral anticoagulation 56 invasive aspergillosis 56 fatal myocardial infarction 56 hemoglobin A1c levels 56 systemic embolism 56 venous thromboembolic 56 Coronary Artery Bypass Graft 56 UA NSTEMI 56 tumor recurrence 56 percutaneous intervention 55 resuscitated cardiac arrest 55 nicardipine 55 undergoing coronary artery 55 renal scarring 55 pulmonary capillary wedge 55 preventable readmissions 55 stent implantation 55 β blockers 55 confidence interval CI 55 elective PCI 55 Decompensated Heart Failure 55 infarction STEMI 55 Colorectal cancer screening 55 VTEs 55 stent thrombosis 55 aldosterone antagonist 55 NIHSS score 55 cerebrovascular accidents 55 cytoreductive surgery 55 antiplatelet therapy 55 postoperative hemorrhage 55 estimated glomerular filtration 55 systolic hypertension 55 ICD implants 55 postop 55 unstable angina 55 biochemical recurrence 55 stenting 55 intraoperative complications 55 underwent CABG 55 CABG 55 CABG surgeries 55 severe neutropenia 55 HbA1c levels 55 Hypotension 55 SLNB 55 abnormal Pap test 55 carotid endarterectomy CEA 55 postoperative 55 baseline HbA1c 55 untreated sleep apnea 55 morphometric vertebral fractures 55 Bloodstream Infections 55 lung resection 55 mortality 55 dual antiplatelet therapy 55 vertebral fracture 55 pelvic lymphadenectomy 55 uncontrolled asthma 55 pulmonary dysfunction 55 morbidity mortality 55 cytogenetic response 55 angioplasty stenting 55 EDSS scores 55 eplerenone 55 Kaplan Meier estimates 55 hypoglycemic episodes 55 VTE 55 stable angina 55 venous thromboembolism 55 onset atrial fibrillation 55 paroxysmal AF 55 FluCAM arm 55 symptomatic intracranial 55 NYHA functional class 55 microalbuminuria 55 aneurysmal subarachnoid hemorrhage 55 NYHA class 55 R0 resection 55 cirrhotic patients 55 DES implantation 55 sustained virological response 55 NATRECOR R 55 IIIa inhibitors 55 ischemic cardiomyopathy 55 symptomatic hyponatremia 55 suicide ideation 55 aldosterone antagonists 55 nonvertebral fractures 55 Hb A1C 55 serum potassium 55 ventricular arrhythmia 55 ventricular tachyarrhythmia 54 deep venous thromboses 54 untreated OSA 54 ATACAND 54 cardiovascular mortality 54 intracerebral haemorrhage 54 spontaneous preterm delivery 54 troponin T 54 systemic corticosteroids 54 subtrochanteric 54 OAB symptoms 54 proximal DVT 54 percutaneous coronary intervention 54 prolonged QT interval 54 preterm deliveries 54 alteplase 54 Apgar scores 54 endophthalmitis 54 EXJADE 54 hip fracture 54 ICD therapy 54 asymptomatic carotid stenosis 54 threatening ventricular arrhythmias 54 Postoperative complications 54 clopidogrel 54 perioperative 54 dysrhythmias 54 Target Lesion Revascularization TLR 54 COPD exacerbation 54 unstable angina pectoris 54 lipid lowering therapy 54 Fonarow 54 psychiatric comorbidities 54 NYHA Class II 54 intracranial stenosis 54 adenoma recurrence 54 LVEF 54 intima media thickness 54 D dimer 54 graft occlusion 54 vaginal hysterectomy 54 atrioventricular block 54 TEAEs 54 cardiac resynchronization 54 uncontrolled bleeding 54 cerebral vasospasm 54 glycated hemoglobin levels 54 aneurysm rupture 54 confirmed CCyR 54 dalteparin 54 nonoperative treatment 54 enoxaparin 54 stenting procedures 54 symptomatic carotid stenosis 54 TURBT 54 extracolonic findings 54 preserved ejection fraction 54 Unstable Angina 54 death reinfarction 54 CRBSIs 54 NNT = 54 warfarin therapy 54 HBeAg seroconversion 54 Venous thromboembolism 54 perioperative morbidity 54 ofpatients 54 nonobstructive CAD 54 BYSTOLIC 54 hepatic resection 54 % CI #.#-#.# [008] 54 angiographic outcomes 54 PICSO ® 54 opioid overdose 54 sotalol 54 acute decompensation 54 adenomatous polyps 54 hypertensive patients 54 variceal 54 microvascular disease 54 STEMI 54 nonvertebral fracture 54 febrile neutropenia 54 XIENCE V PROMUS Stent 54 bolus dose 54 endometrial carcinoma 54 polyp recurrence 54 antiarrhythmic drugs 54 antihypertensive medications 54 #.#/#.# mmHg [001] 54 ventricular tachycardia VT 54 serum phosphorous 54 adverse perinatal 54 nondiabetic patients 54 Percutaneous Coronary Intervention 54 antiplatelet medication 54 oral corticosteroids 54 unnecessary hospitalizations 54 incontinence episodes 54 GP IIb IIIa inhibitors 54 CHD CVD 54 acute urinary retention 54 cilostazol 54 aspirin beta blockers 53 antiplatelet medications 53 pneumonectomy 53 multivessel disease 53 % CI #.#-#.# [007] 53 tubing misconnections 53 ADHF 53 interferon ribavirin 53 renal dysfunction 53 stroke myocardial infarction 53 Myocardial infarction 53 PASI scores 53 intracerebral hemorrhage 53 β blocker 53 decompensation 53 Taxus Stent 53 underwent percutaneous coronary 53 nocturnal hypoglycaemia 53 antidepressant therapy 53 biochemical relapse 53 beta blocker 53 GIK infusion 53 reoperation 53 thrombolysis 53 NATRECOR ® 53 underwent coronary angiography 53 lung resections 53 subclinical hypothyroidism 53 torsade de pointes 53 hypoglycaemic episodes 53 ischemic complications 53 coronary interventions 53 oral anticoagulant therapy 53 corneal infection 53 mechanically ventilated patients 53 hospital readmissions 53 carotid artery blockage 53 nonsignificant 53 urgent revascularization 53 contrast induced nephropathy 53 systolic dysfunction 53 eGFR 53 paroxysmal atrial fibrillation 53 anaphylactic episodes 53 non valvular atrial 53 exacerbations 53 C. difficile colitis 53 underwent resection 53 ximelagatran 53 post operatively 53 acute aortic dissection 53 neonatal morbidity 53 anthracycline therapy 53 URTI 53 prescribed statins 53 recurrent wheezing 53 venous blood clots 53 GWTG 53 acute coronary syndromes ACS 53 cTnT levels 53 platelet inhibition 53 reintubation 53 neurologic sequelae 53 OGTT 53 preserved systolic 53 defibrillator CRT D 53 target lesion revascularization 53 paclitaxel eluting stents 53 TAXUS p value 53 liver histology 53 postpartum haemorrhage 53 intravitreal injections 53 Crohn Disease Activity 53 discontinuations due 53 chlamydia infection 53 PONV 53 % CI #.#-#.# [006] 53 CHD mortality 53 cardiopulmonary bypass CPB 53 endotracheal intubation 53 nonoperative 53 adenoidectomy 53 rhythm disturbances 53 gastrointestinal perforations 53 hepatectomy 53 ARIXTRA 53 anticlotting drugs 53 HbA 1c levels 53 cesarean delivery 53 hyperbilirubinemia 53 Stomach stapling 53 bypass graft CABG surgery 53 advanced neoplasia 53 epidural analgesia 53 Hospitalization 53 prescribed beta blocker 53 liver resection 53 sternal wound infections 53 recanalization 53 thromboembolic complications 53 spontaneous vaginal 53 pulmonary embolism PE 53 CVD mortality 53 kidney transplant recipients 53 OPCAB 53 ventricular fibrillation VF 53 needlestick 53 P = .# 53 fragility fracture 53 concomitant antibiotics 53 fibrinolysis 53 pericardial effusion 53 rt PA 53 secondary efficacy endpoint 53 corticosteroid therapy 53 fibrinolytic therapy 53 malignant neoplasm 53 venous thrombosis 53 unfractionated heparin 53 bisphosphonate therapy 53 irbesartan 53 arterial stenosis 53 placenta accreta 53 pCR 53 FFR guided 53 Recurrences 53 rituximab infusion 53 severe hypoglycaemia 53 debulking surgery 53 bacteriuria 53 noncancer 53 liver transplant recipients 53 virological response 53 atherothrombotic 53 invasive coronary angiography 52 Severe hypoglycemia 52 coronary artery bypass grafts 52 acutely decompensated heart 52 HIV HCV coinfected 52 symptom onset 52 clot busting therapy 52 serum sodium 52 albuminuria 52 ischemia driven 52 A1C levels 52 endometrial thickness 52 depressive symptomatology 52 TAVR 52 cystectomy 52 cerebrovascular 52 events MACE 52 confirmed thrombotic cardiovascular 52 adenotonsillectomy 52 C. diff infections 52 Operative mortality 52 bowel resection 52 ventricular tachyarrhythmias 52 perinatal mortality 52 carotid artery stenting CAS 52 hypoxemia 52 heparin induced thrombocytopenia 52 coronary stenosis 52 dose atorvastatin 52 Skin sterol 52 nonfatal cardiovascular 52 cryptogenic stroke 52 breast cancer recurrences 52 nonadherent 52 myocardial reperfusion 52 coronary artery bypass 52 thyroidectomy 52 colorectal adenoma 52 HbA1C 52 bloodstream infection 52 gastrointestinal hemorrhage 52 electrical cardioversion 52 QTc interval 52 depressive symptom 52 cecal intubation 52 elevated creatinine 52 acute coronary syndromes 52 PRADAXA 52 preoperative chemotherapy 52 CABG surgery 52 chlamydial infection 52 glycated hemoglobin HbA1c 52 rtPA 52 EBRT 52 XIENCE V vs. 52 cardiac dysfunction 52 syncopal episode 52 pulmonary resection 52 androgen deprivation 52 vaccinees 52 TAXUS Express Stent 52 Acute Coronary Syndromes 52 antiarrhythmic drug 52 CMV disease 52 acute cholecystitis 52 spinal cord compression 52 inhospital complications 52 Coronary artery bypass graft 52 unstable angina chest 52 salpingo oophorectomy 52 pyelonephritis 52 psychiatric comorbidity 52 S. aureus infection 52 thromboses 52 #mmHg [001] 52 IOP lowering 52 antithrombotic therapies 52 posttraumatic stress disorder PTSD 52 C difficile infection 52 ARCOXIA 52 advanced adenoma 52 incisional hernias 52 adverse cytogenetics 52 Liver transplantation 52 recurrent ischemic stroke 52 BSIs 52 antibiotic regimens 52 postoperative sepsis 52 hemodynamically stable 52 bystander CPR 52 wound dehiscence 52 fetal malformations 52 HAART initiation 52 MS DRGs 52 CYPHER ® 52 intraoperative bleeding 52 coronary revascularisation 52 radical nephrectomy 52 torsades de pointes 52 arrhythmias 52 infarct size 52 preoperative PSA 52 Lamictal XR 52 postoperative chemotherapy 52 CPAP adherence 52 coronary angiography 52 Complication rates 52 CYPHER Stent 52 serum urate 52 intravesical therapy 52 depressive symptoms 52 Afib 52 elevated troponin 52 OSAHS 52 pulmonary artery catheters 52 detrusor overactivity 52 bacteremia 52 receiving VICTRELIS 52 recurrent ischemic 52 ticlopidine 52 tracheal intubation 52 QTcF 52 MADRS score 52 undergoing bariatric surgery 52 advanced adenomas 52 retinal thickness 52 gout flares 52 catheter colonization 52 comorbidity 52 infective endocarditis 52 nephrotoxicity 52 urgent coronary revascularization 52 mortality morbidity 52 circulating EPCs 52 intravenous tPA 52 neutrophil counts 52 Montgomery Asberg Depression 52 Kyphon Balloon Kyphoplasty 52 postpartum hemorrhage 52 Cesarean deliveries 52 apneic 52 RLS symptoms 52 GERD symptoms 52 cardioembolic stroke 52 urine albumin 52 bloodstream infections 52 cranial irradiation 52 mitral regurgitation 52 ischemic stroke 52 stent thromboses 52 segment elevation myocardial 52 radical prostatectomy RP 52 mL/min/#.# m 2 52 diastolic heart 52 left ventricular systolic 52 status epilepticus 52 elevated CRP 52 intubations 52 associated bloodstream infections 52 ST Segment Elevation 52 cardiac 52 undergoing radical prostatectomy 52 gastrointestinal bleeds 52 progression TTP 52 Ebstein anomaly 52 tenecteplase 51 glomerular filtration 51 polyp detection 51 vasopressor 51 symptomatic intracranial hemorrhage 51 sudden cardiac death 51 venous thromboembolism VTE 51 PRADAXA #mg 51 T2DM 51 stent insertion 51 upper endoscopy 51 interstitial pneumonia 51 elevated LDL cholesterol 51 lymphocyte count 51 LAGB 51 invasive diagnostic 51 NYHA Class III 51 SGRQ 51 suicidal ideation 51 VAD implantation 51 Thrombolysis 51 nosocomial infection 51 Acinetobacter infections 51 coinfected patients 51 p = #.# [003] 51 recurrent UTI 51 thyrotropin levels 51 Chlamydia infection 51 psychiatric morbidity 51 nighttime awakenings 51 Index CDAI 51 HAM D# scores 51 perinatal morbidity 51 atrial arrhythmias 51 comorbidities 51 Score DAS# 51 carotid artery stenting 51 tamoxifen therapy 51 chlorambucil 51 nesiritide 51 fondaparinux 51 multisystem organ failure 51 CYPHER ® Stent 51 concomitant medications 51 anticoagulation clinics 51 Secondary endpoints included 51 tumor resection 51 parathyroidectomy 51 p = NS 51 empyema 51 prophylactic antibiotics 51 XIENCE V demonstrated 51 hip fractures 51 ribavirin therapy 51 corticosteroid dose 51 trabeculectomy 51 tumor lysis syndrome 51 Recurrence 51 coronary bypass surgeries 51 locoregional recurrence 51 SRBD 51 nonischemic 51 nonischemic cardiomyopathy 51 verapamil 51 recurrences 51 incomplete revascularization 51 MULTAQ 51 Ejection Fraction 51 dexmedetomidine 51 cerebral infarction 51 myocardial infarction congestive heart 51 serum calcium levels 51 everolimus eluting stents 51 hematuria 51 rFVIIa 51 candesartan 51 Postoperative 51 renal insufficiency 51 necrotizing pancreatitis 51 prescribed opioids 51 CI #.#-#.# [001] 51 neutropenic fever 51 adrenal insufficiency 51 peritoneal cancer 51 venous thromboembolisms 51 proliferative diabetic retinopathy 51 urine NGAL 51 chronic hemodialysis 51 asymptomatic AF 51 KIF6 carriers 51 carotid revascularization 51 CK MB 51 extrapyramidal symptoms 51 prespecified 51 GI bleeding 51 prednisone prednisolone 51 TAVI 51 abnormal mammogram 51 obstructive CAD 51 coagulation abnormalities 51 Unstable angina 51 related bloodstream infections 51 prodromal symptoms 51 glomerular filtration rate 51 elevated ALT 51 ACR Pedi 51 coronary CTA 51 clopidogrel pretreatment 51 suicide attempters 51 interquartile range 51 uncoated stents 51 microvascular complications 51 hemodilution 51 Arrhythmias 51 sleeve lobectomy 51 prolongs survival 51 Scale EDSS score 51 glycoprotein IIb IIIa inhibitors 51 Exacerbations 51 complete cytogenetic response 51 abnormal uterine bleeding 51 repeat paracentesis 51 Coronary Artery Bypass Grafting 51 malignant neoplasms 51 coronary heart 51 complex fusions 51 ALND 51 clot dissolving drug 51 hematologic toxicity 51 Acute Myocardial Infarction 51 International Normalized Ratio 51 carotid intima media 51 stent thrombosis blood clots 51 HES CEL 51 PPCM 51 imatinib therapy 51 Recurrent Stroke 51 antiplatelet drugs 51 AFib 51 angina chest 51 left ventricular hypertrophy 51 cardiovascular disease CVD 51 serum uric acid 51 cardiovascular morbidity 51 pancreatectomy 51 elevated IOP 51 CPAP therapy 51 Medication errors 51 apnea hypopnea 51 lightheadedness fainting 51 myocardial infarctions MIs 51 symptomatic intracerebral hemorrhage 51 perinatal complications 51 parkinsonian symptoms 51 duplex ultrasonography 51 cardiovascular disease 51 neostigmine 51 acute myocardial infarction MI 51 clinically localized prostate 51 pulmonary thromboembolism 51 NIH CPSI 51 coronary 51 tolvaptan 51 elevated bilirubin 51 MitraClip device 51 hemorrhagic strokes 51 disease progression 51 candidemia 51 QTc intervals 51 events ADEs 51 systemic hypotension 51 virologic response 51 CMV reactivation 51 asthma flare ups 51 cerebrovascular disease 51 REYATAZ r arm 51 HAM D# 51 angiotensin II receptor blockers 51 serum sodium levels 51 ambulatory settings 51 endoscopic remission 51 hemoglobin A1c HbA1c 51 atherothrombosis 51 NSQIP 51 thrombolytic agents 51 Influenza vaccination 51 urinary symptoms 51 palliation 51 CR nPR 51 lamivudine monotherapy 51 oxycodone CR 51 atypical antipsychotic drugs 51 recurrent miscarriage 51 amiodarone 51 coronary blockages 51 Bivalirudin 51 nadroparin 51 fetal chromosomal 51 Hydroxyurea 51 hypertension congestive heart 51 symptomatic pulmonary embolism 51 threatening arrhythmias 51 defibrillator implantation 51 confidence interval #.#-#.# 51 aspirin regimen 51 morbidity 51 carotid IMT 51 bariatric surgical 51 normothermia 51 undergo bariatric surgery 51 GnRH agonists 51 clot busting medication 51 proteinuria 51 antihypertensive therapy 51 RSV hospitalizations 51 MMSE score 51 antidepressant monotherapy 51 maternal morbidity 51 elective cesarean delivery 51 Thrombocytopenia 51 FOLFOX4 51 angiotensin converting enzyme inhibitors 50 Acute Coronary Syndrome 50 bariatric procedures 50 symptom flare ups 50 acutely decompensated congestive heart 50 C. diff infection 50 pneumococcal vaccination 50 NSAID therapy 50 left ventricular ejection 50 Cardiovascular Events 50 Percutaneous Coronary Interventions 50 achieved sustained virological 50 Sustained Virological Response 50 Cardiopulmonary bypass 50 clinically insignificant 50 prescribing beta blockers 50 malperfusion 50 mm Hg 50 Patient Outcomes 50 SCD HeFT 50 DAS# [002] 50 mmHg diastolic 50 diagnostic angiography 50 Venous Thromboembolism 50 angioplasty 50 undetectable PSA 50 drank decaffeinated coffee 50 GWTG CAD 50 virological failure 50 CIN3 50 vasospasm 50 relapse 50 clinically evaluable patients 50 oral corticosteroid 50 Acute myocardial infarction 50 sociodemographic characteristics 50 androgen suppression 50 radical retropubic prostatectomy 50 conventional angiography 50 coronary revascularizations 50 cardiac tamponade 50 vertebral fractures 50 hemodialysis patients 50 procalcitonin 50 low birthweight infants 50 hemoglobin A1C 50 hepatic failure 50 afterload 50 hysterectomies performed 50 dose clopidogrel 50 CI #.#-#.# [002] 50 spontaneous preterm birth 50 oxygen saturations 50 HRQoL 50 Contrast Induced Nephropathy CIN 50 stratifying patients 50 renarrowing 50 spinal metastases 50 transradial PCI 50 restenosis reblockage 50 HCV antibody 50 TAXUS Stent 50 breast cancer recurrence 50 symptom exacerbation 50 perinatal transmission 50 virologic suppression 50 bronchial thermoplasty 50 hepatorenal syndrome 50 venous clots 50 HbA 1C 50 subarachnoid hemorrhages 50 Adjuvant chemotherapy 50 luminal diameter 50 lower extremity amputation 50 insulin detemir 50 GI bleeds 50 elevated uric acid 50 hemodynamic parameters 50 beta blockers 50 abnormal Pap smear 50 preterm delivery 50 macrovascular 50 precancerous cervical